WMS vaccine recommendations – now also available in Japanese

The World Muscle Society (WMS) has been providing advice for people with neuromuscular disorders, and their healthcare providers since the start of the COVID-19 pandemic. There is now also a document aiming to answer questions regarding the newly developed vaccines against Coronavirus SARS-CoV2, asked by people with neuromuscular disorders. This is a rapidly developing field, and the WMS will keep this advice in regular review. We have been delighted that WMS members from around the globe have now translated the documents into so many languages which demonstrates the true value of sharing this information as well as the international reach the neuromuscular community has. The latest translation to be added is Japanese, which has been kindly coordinated by Prof Yoshihide Sunada, Kawasaki Medical School, Kurashiki-City, Okayama, Japan.

View the Covid-19 and people with neuromuscular disorders: World Muscle Society position and advice here

View Covid-19 and people with neuromuscular disorders: World Muscle Society advice - Vaccines here

For any further queries or if you wish to add a translated version in another language please contact Clare Beach, WMS Secretariat

Published on 26 March 2021.

Related

24 Jun 2021 Meet the WMS Young Myologist of the Year Presidents Prize Award Winner 2020

07 Jun 2021 An example of how career growth shapes your future role

04 Jun 2021 Petra Kaufmann's Perspective on Industry Careers

WMS Twitter Feed
WMS Facebook Feed